Alchemab Therapeutics in Cambridge has secured £25 million ($34m) additional Series A funding from the British Business Bank.
Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.
Clinical-stage biotech Alchemab Therapeutics has extended its series A financing with a £25 million (USD $34 million) investment from the British Business Bank ? the Bank's largest investment in a ...
As AI places unprecedented demand on ageing digital infrastructure, ESG compliance is shifting from a tick box exercise to a critical driver of investor and customer trust. Sujata Kukreja, Global ...
The hair tools brand has launched artificial intelligence (AI)-powered GHD Sculpt to mark its 25th anniversary, which it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results